Baxter International | BAX - Pre Tax Profit


Baxter International reported $362M in Pre-Tax Profit for its fiscal quarter ending in June of 2026.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
AngioDynamics USD -6.4M 5.03M Sep/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 394K 1.97M Mar/2026
Baxter International USD 362M 368M Jun/2026
Becton, Dickinson and Co. USD 39M 354M Mar/2026
Boston Scientific USD 1.42B 261M Jun/2026
Cooper Companies USD 192.2M 75.4M Dec/2025
Dexcom USD 269.5M 71.2M Mar/2026
Edwards Lifesciences USD 529.3M 90.4M Jun/2026
Fresenius EUR 535M 42M Jun/2026
Globus Medical USD 157.07M 12.16M Mar/2026
Halozyme Therapeutics USD 180.33M 281.18M Mar/2026
ICU Medical USD -3.97M 11.93M Mar/2026
Inogen USD -6.06M 467K Sep/2024
Insulet USD 118.7M 5.7M Jun/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
Intuitive Surgical USD 940.4M 15.2M Mar/2026
J&J USD 8.66B 839M Jun/2026
Laboratory Of America USD 8.61B 121.8M Jun/2026
Medtronic USD 2.45B 1.04B Mar/2026
Merit Medical Systems USD 53.55M 2.49M Mar/2026
Quest Diagnostics USD 334M 4M Mar/2026
Smith & Nephew USD 469M 70M Dec/2025
Stryker USD 850M 855M Mar/2026
Tandem Diabetes Care USD -19.88M 24.56M Mar/2026
Teleflex USD -3.83M 222.77M Mar/2026
Terumo JPY 90.32B 58.66B Jun/2026
Zimmer Biomet Holdings USD 487.5M 186.2M Jun/2026